Data Science Impacting the Pharmaceutical Industry
Part I: Drug Discovery Applications
28-Aug-2020
Global
Technology Research
D9B0-01-00-00-00
HC03332-GL-TR_24683
Data science and AI have the potential to transform drug discovery in terms of costs, speed and efficiency. With explosion in biomedical data, data sharing and analysis platforms have surged. AI technologies are moving to the next phase of advancements, and when combined with other emerging tech areas, AI is expected to witness a full fledged adoption by pharma and biotech companies in the next 4-5 years
The Strategic Imperative 8™
The Strategic Imperative 8™ (continued)
The Impact of the Top Three Strategic Imperatives on Data Science in Drug Discovery Industry
ABOUT THE GROWTH PIPELINE ENGINE™
Growth Opportunities Fuel the Growth Pipeline Engine™
Research Methodology
Research Methodology (continued)
1.1 Role of Big Data and AI in Drug Discovery
1.2 Advantages of Data Science Augmentation in Drug Discovery
1.3 Improvement in KPIs using AI/Big Data in Drug Discovery
1.4 Areas of Focus Using AI and Big Data in Drug Discovery
1.5 Challenges in Leveraging Big Data and AI In Drug Discovery
2.1 Data Science- Technology Architecture in Drug Discovery
2.2 Applications of AI In Drug Discovery
2.3 Emerging Technology Trends in Data Science Technologies in Drug Discovery
2.4 AI In Drug Discovery – Tech Convergence Areas to Explore
3.1 Evolving Landscape with Rise in Industry Partnerships and Investments
3.2 Ecosystem of Pharma and AI Companies for Drug Discovery
3.3 Key Technology Management Strategies
3.4 Highlights of AI Enabled Drug Discovery Partnerships
3.5 Highlights of Big Pharma Engagement & Investments in AI Drug Discovery
3.6 Scaling up Long Term Research Partnerships and JVs
3.7 Strengthen Market Position with Acquisitions and Licensing
3.8 Accelerate Large Scale Data Sharing via Consortia
4.1 Atomwise
4.2 Exscientia
4.3 Insilico Medicine
4.4 BERG AI
4.5 Lantern Pharma
4.6 Cyclica
4.7 Recursion Pharma
4.8 nference
5.1 Disease Focus Areas for AI enabled Drug Discovery
5.2 Applications of AI and Big Data in Oncology Precision Medicine
5.3 Strategic Imperatives for AI Enabled Oncology Precision Medicine
5.4 Applications in Neurology/Neurodegenerative Disorders
5.5 Strategic Imperatives for AI Enabled Drug Discovery for Neurological/Neurodegenerative Diseases
5.6 Applications in Infectious Diseases/COVID-19 Drug Discovery and Repurposing
5.7 Strategic Imperatives for AI Enabled Drug Discovery for Infectious Diseases/SARS-CoV-2
5.8 Accelerating COVID-19 Drug Discovery with AI and Data Science
5.9 Applications in Orphan Diseases
6.1 Growth Opportunity 1: Drug “Repurposing” Using AI and Big Data
6.1 Growth Opportunity 1: Drug “Repurposing” Using AI and Big Data (continued)
6.2 Growth Opportunity 2: Lead Optimization Using AI – Drug Property and Bioactivity Prediction
6.3 Growth opportunity 2: Use of AI for Drug Property and Bioactivity Prediction Could Potentially Reduce Number of Failures in Clinical Development
6.4 Growth opportunity 3: Identify novel candidates and De novo drug synthesis using AI
6.4 Growth Opportunity 3: Identify Novel Candidates and De Novo Drug Design Using AI (continued)
7.1 IP Overview of AI Enabled Drug Discovery
7.2 Top Pharmaceutical/Biotech Patent Holders
8.1 Types of AI algorithms
9.1 Key Industry Contacts
9.1 Key Industry Contacts (continued)
10.1 YOUR NEXT STEPS
10.2 WHY FROST, WHY NOW?
Legal Disclaimer
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
17 Nov 2026 | Global | Frost Radar
Frost Radar™: Quantum-Grade Sensor Technology Ecosystem for Healthcare Applications, 2026
Quantum-grade sensors are advancing healthcare by leveraging quantum phenomena to enable highly sensitive, precise, and non-invasive measurements of biological signals and physiological parameters. These innovations enhance diagnostic accuracy, disease monitoring, brain activity measurement, and ear...
16 Nov 2026 | North America | Frost Radar
Frost Radar™: Healthcare Data Interoperability Platforms and Integration Engines in North America, 2026
This Frost Radar™ analyzes the healthcare data platform and integration engine vendors that enable healthcare organization to improve the exchange, utilization, contextualization, and management of clinical, operational, financial, and administrative data. Data issues, AI adoption, and solution gove...
03 Nov 2026 | North America | Market Research
Enterprise Imaging Market, United States, 2025–2030
Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...
02 Nov 2026 | Global | Market Research
Continuous Glucose Monitoring Market, Global, 2026
The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-cou...
28 Oct 2026 | Global | Frost Radar
Frost Radar™: Health Monitoring Wearable Solutions, 2026
The health monitoring wearables industry is undergoing a profound transformation as competitive advantage shifts from device hardware to integrated digital health ecosystems. Market leaders are differentiating through clinically validated health insights, longitudinal data platforms, AI-enabled anal...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.